Entrada Therapeutics (TRDA) Selling, General & Administrative (2020 - 2026)
Entrada Therapeutics (TRDA) reported Selling, General & Administrative of $10.49 million for Q2 2026, down 3.9% from $10.92 million a year earlier but up 3.6% from the prior quarter.
Powered by 
Analysis
Entrada Therapeutics (TRDA) Selling, General & Administrative (2020 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Entrada Therapeutics' Selling, General & Administrative came in at $40.47 million, down 1.4% year-over-year; for FY2025, it was $41.05 million, up 6.7% from FY2024.
- Selling, General & Administrative has increased for five consecutive years, with a five-year compound annual growth rate of 49.1% (FY2020 to FY2025).
- By year, Selling, General & Administrative came in at $38.47 million in FY2024 (+19.1%), $32.29 million in FY2023 (+5.4%), $30.64 million in FY2022 (+101.6%) and $15.2 million in FY2021 (+173.2%).
- Five-year quarterly Selling, General & Administrative spans a low of $3.85 million in Q3 2021 and a high of $10.92 million in Q2 2025.
- Year over year, Selling, General & Administrative has now declined in each of the last three quarters, with growth averaging 8.6% over the last eight quarters.
- The high point for year-over-year Selling, General & Administrative in five years was Q4 2021 (growth of 205.4%); the low point was Q4 2023 (a decline of 12.6%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $10.12 million (Q1 2026), $9.55 million (Q4 2025) and $10.3 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 6.43 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 3.63 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.90 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -3.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -5.65 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 1.75 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.92 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 3.41 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 582.20 Mn |
| 10 | Entrada Therapeutics | 247.25 Mn | 247.25 Mn | - | 10.49 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.49 Mn |
| Mar 31, 2026 | 10.12 Mn |
| Dec 31, 2025 | 9.55 Mn |
| Sep 30, 2025 | 10.30 Mn |
| Jun 30, 2025 | 10.92 Mn |
| Mar 31, 2025 | 10.27 Mn |
| Dec 31, 2024 | 9.86 Mn |
| Sep 30, 2024 | 9.97 Mn |
| Jun 30, 2024 | 9.24 Mn |
| Mar 31, 2024 | 9.40 Mn |
| Dec 31, 2023 | 8.65 Mn |
| Sep 30, 2023 | 7.53 Mn |
| Jun 30, 2023 | 8.17 Mn |
| Mar 31, 2023 | 7.94 Mn |
| Dec 31, 2022 | 9.89 Mn |
| Sep 30, 2022 | 6.98 Mn |
| Jun 30, 2022 | 7.33 Mn |
| Mar 31, 2022 | 6.43 Mn |
| Dec 31, 2021 | 6.10 Mn |
| Sep 30, 2021 | 3.85 Mn |
API Access
Entrada Therapeutics Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=TRDA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "TRDA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=TRDA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();